These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

608 related items for PubMed ID: 22078846

  • 1. Treating anemia associated with chronic renal failure with erythropoiesis stimulators: recombinant human erythropoietin might be the best among the available choices.
    Trkulja V.
    Med Hypotheses; 2012 Jan; 78(1):157-61. PubMed ID: 22078846
    [Abstract] [Full Text] [Related]

  • 2. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y, Nishi S, Akiba T, Hirakata H, Iseki K, Kubota M, Kuriyama S, Komatsu Y, Suzuki M, Nakai S, Hattori M, Babazono T, Hiramatsu M, Yamamoto H, Bessho M, Akizawa T.
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [Abstract] [Full Text] [Related]

  • 3. Serum erythropoietin levels and their correlation with the erythropoietic system in hemodialysis patients and renal allograft recipients.
    Khosroshahi HT, Shoja MM, Tubbs RS, Estakhri R, Ardalan MR.
    Transplant Proc; 2007 May; 39(4):1051-3. PubMed ID: 17524889
    [Abstract] [Full Text] [Related]

  • 4. Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients.
    Cody J, Daly C, Campbell M, Donaldson C, Grant A, Khan I, Pennington S, Vale L, Wallace S, MacLeod A.
    Cochrane Database Syst Rev; 2001 May; (4):CD003266. PubMed ID: 11687180
    [Abstract] [Full Text] [Related]

  • 5. Novel erythropoiesis-stimulating agents: a new era in anemia management.
    Macdougall IC.
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):200-7. PubMed ID: 18077782
    [Abstract] [Full Text] [Related]

  • 6. [Chemical structure, biotechnical production and clinical use of recombinant erythropoietin].
    Fandrey JK, Jelkmann WE.
    Z Gesamte Inn Med; 1992 Jun; 47(6):231-8. PubMed ID: 1642021
    [Abstract] [Full Text] [Related]

  • 7. [Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency].
    Dimković N.
    Med Pregl; 2001 Jun; 54(5-6):235-40. PubMed ID: 11759218
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability of recombinant human erythropoietin treatment in pre-dialysis patients: results of a multicenter study.
    Albertazzi A, Di Liberato L, Daniele F, Battistel V, Colombi L.
    Int J Artif Organs; 1998 Jan; 21(1):12-8. PubMed ID: 9554820
    [Abstract] [Full Text] [Related]

  • 10. [Effect of the treatment with human recombinant erythropoietin on anemia in children with end-stage kidney failure. French multicenter study].
    Sinnassamy P, Andre JL, Treize G, Leroy B.
    Arch Fr Pediatr; 1993 Mar; 50(3):201-8. PubMed ID: 8338412
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. CERA: third-generation erythropoiesis-stimulating agent.
    Topf JM.
    Expert Opin Pharmacother; 2008 Apr; 9(5):839-49. PubMed ID: 18345959
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Lymphocyte 5'-nucleotidase and aminopeptidase N activity in patients on maintenance hemodialysis treated with human recombinant erythropoietin and 1-alpha-D3.
    Stefanovic V, Mitić-Zlatkovic M, Radivojevic J, Vlahovic P.
    Ren Fail; 2005 Apr; 27(3):283-8. PubMed ID: 15957544
    [Abstract] [Full Text] [Related]

  • 19. Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients.
    Cody J, Daly C, Campbell M, Donaldson C, Khan I, Rabindranath K, Vale L, Wallace S, Macleod A.
    Cochrane Database Syst Rev; 2005 Jul 20; (3):CD003266. PubMed ID: 16034896
    [Abstract] [Full Text] [Related]

  • 20. The use of recombinant human erythropoietin (EPO) to correct the anemia of end-stage renal disease: a progress report.
    Adamson W, Egrie JC, Browne JK, Downing MR, Eschbach W.
    Behring Inst Mitt; 1988 Aug 20; (83):188-92. PubMed ID: 3071336
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.